Colafemina ACE, Santos BC, Cabeza BC, Neto IJC, Faustino ISP, Silva ARS, Vargas PA, Lopes MA. Consequences of interrupted follow-up in head and neck cancer and oral potentially malignant disorders patients due to the COVID-19 pandemic. Med Oral Patol Oral Cir Bucal. 2026 Jan 1;31 (1):e73-e81.

doi:10.4317/medoral.27561

https://dx.doi.org/doi:10.4317/medoral.27561

1. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92
https://doi.org/10.1038/s41572-020-00224-3
PMid:33243986 PMCid:PMC7944998

2. Louredo BV, Vargas PA, Pérez-de-Oliveira ME, Lopes MA, Kowalski LP, Curado MP. Epidemiology and survival outcomes of lip, oral cavity, and oropharyngeal squamous cell carcinoma in a southeast Brazilian population. Med Oral Patol Oral Cir Bucal. 2022;27(3):e274-e284
https://doi.org/10.4317/medoral.25147
PMid:35368013 PMCid:PMC9054163

3. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):582-590
https://doi.org/10.1016/j.oooo.2018.03.011
PMid:29673799

4. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612-627
https://doi.org/10.1016/j.oooo.2017.12.011
PMid:29396319

5. Caldeira PC, Ribeiro ILA, Borges AC, et al. Impact of the COVID-19 pandemic on public university laboratories of oral and maxillofacial pathology: A Brazilian multicenter study. Oral Dis. 2023;29(1):e1-e9
https://doi.org/10.1111/odi.14136
PMid:35080084

6. da Cunha AR, Antunes JLF, Martins MD, Petti S, Hugo FN. The impact of the COVID-19 pandemic on oral biopsies in the Brazilian National Health System. Oral Dis. 2022;28(1):925-928
https://doi.org/10.1111/odi.13620
PMid:32852882 PMCid:PMC7461360

7. Tevetoğlu F, Kara CO, Aliyeva C, Yıldırım R. Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2021;278(11):5081-5086
https://doi.org/10.1007/s00405-021-06728-2
PMid:33674926 PMCid:PMC7935695

8. Kiong KL, Guo T, Yao CMKL, Gross ND, St John MA. The impact of COVID-19 on head and neck cancer diagnosis and disease extent. Head Neck. 2020;42(10):2134-2139
https://doi.org/10.1002/hed.26202
PMid:32459061

9. Brody RM, Albergotti WG, Shimunov D, et al. Changes in head and neck oncologic practice during the COVID-19 pandemic. Head Neck. 2020;42(7):1448-1453
https://doi.org/10.1002/hed.26233
PMid:32357380 PMCid:PMC7267666

10. da Cunha AR, Antunes JLF, Martins MD, Petti S, Hugo FN. The impact of the COVID-19 pandemic on oral biopsies in the Brazilian National Health System. Oral Dis. 2022;28(Suppl 1):925-928
https://doi.org/10.1111/odi.13620
PMid:32852882 PMCid:PMC7461360

11. Popovic M, Fiano V, Moirano G, et al. The impact of the COVID-19 pandemic on head and neck cancer diagnosis in the Piedmont region, Italy: Interrupted time-series analysis. Front Public Health. 2022;10:809283
https://doi.org/10.3389/fpubh.2022.809283
PMid:35265573 PMCid:PMC8899030

12. Ying X, Bi J, Ding Y, et al. Management and outcomes of patients with radiotherapy interruption during the COVID-19 pandemic. Front Oncol. 2021;11:754838
https://doi.org/10.3389/fonc.2021.754838
PMid:34868962 PMCid:PMC8639682

13. Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, Rivero ERC. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633-640
https://doi.org/10.1111/jop.12726
PMid:29738071

14. Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539-555
https://doi.org/10.1002/hed.26006
PMid:31803979

15. Jäwert F, Nyman J, Olsson E, Adok C, Helmersson M, Öhman J. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer. Oral Oncol. 2021;121:105469
https://doi.org/10.1016/j.oraloncology.2021.105469
PMid:34371451

16. Ramos-García P, González-Moles MÁ, Mello FW, Bagan JV, Warnakulasuriya S. Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta-analysis. Oral Dis. 2021;27(8):1896-1907
https://doi.org/10.1111/odi.13831
PMid:34009718

17. Staines K, Rogers H. Proliferative verrucous leukoplakia: A general dental practitioner-focused clinical review. Br Dent J. 2024;236(4):297-301
https://doi.org/10.1038/s41415-024-7066-8
PMid:38388601 PMCid:PMC10883885

18. Bloom JR, Rodriguez-Russo C, Hsieh K, et al. Head and neck cancer patient population, management, and oncologic outcomes from the COVID-19 pandemic. Curr Oncol. 2024;31(1):436-446
https://doi.org/10.3390/curroncol31010029
PMid:38248114 PMCid:PMC10814981

19. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862-1880
https://doi.org/10.1111/odi.13704
PMid:33128420

20. Mehanna H, West CM, Nutting C, Paleri V. Head and neck cancer-Part 2: Treatment and prognostic factors. BMJ. 2010;341:c4690
https://doi.org/10.1136/bmj.c4690
PMid:20876637

21. Allner M, Rak A, Balk M, Rupp R, Almajali O, Tamse H, et al. Patient-reported outcomes in head and neck cancer: A cross-sectional analysis of quality of life domains across early and advanced UICC stages. Support Care Cancer. 2025;33(4):278
https://doi.org/10.1007/s00520-025-09204-3
PMid:40080201 PMCid:PMC11906576